MedTrace Logo

An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants

NCT02761187 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4253

Last updated 2025-02-24

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to describe contemporary, real-world patterns of participant characteristics, clinical disease presentation, therapeutic regimen chosen, and clinical outcomes in participants with newly diagnosed \[ND\] multiple myeloma (MM) and participants with relapsed/refractory \[R/R\] MM.

Conditions

Interventions

OTHER

No Intervention

As this was an observational study, no intervention was administered.

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-01
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • United States
  • Belgium
  • Brazil
  • China
  • Colombia
  • France
  • Germany
  • Greece
  • Israel
  • Italy
  • Mexico
  • Spain
  • Taiwan
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02761187 on ClinicalTrials.gov